Symbols / PRPO
PRPO Chart
About
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 41.17M |
| Enterprise Value | 42.24M | Income | -1.25M | Sales | 22.80M |
| Book/sh | 7.88 | Cash/sh | 1.32 | Dividend Yield | — |
| Payout | 0.00% | Employees | 54 | IPO | — |
| P/E | — | Forward P/E | 60.26 | PEG | — |
| P/S | 1.81 | P/B | 2.98 | P/C | — |
| EV/EBITDA | -61.66 | EV/Sales | 1.85 | Quick Ratio | 0.96 |
| Current Ratio | 1.27 | Debt/Eq | 25.91 | LT Debt/Eq | — |
| EPS (ttm) | -0.81 | EPS next Y | 0.39 | EPS Growth | — |
| Revenue Growth | 29.90% | Earnings | 2023-11-13 16:00 | ROA | -6.82% |
| ROE | -9.76% | ROIC | — | Gross Margin | 44.82% |
| Oper. Margin | -0.90% | Profit Margin | -5.50% | Shs Outstand | 1.75M |
| Shs Float | 1.42M | Short Float | 0.25% | Short Ratio | 0.44 |
| Short Interest | — | 52W High | 28.50 | 52W Low | 3.90 |
| Beta | 1.22 | Avg Volume | 11.92K | Volume | 31.44K |
| Target Price | — | Recom | None | Prev Close | $23.39 |
| Price | $23.50 | Change | 0.47% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$23.50
Latest analyst target
3. DCF / Fair value
$7.86
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$23.50
Low
—
High
—
Mean
—
- Cancer diagnostics firm erases $1.1M advance, keeps only small loan - Stock Titan hu, 15 Jan 2026 08
- Precipio, Inc. (NASDAQ:PRPO) Stock Rockets 28% But Many Are Still Ignoring The Company - simplywall.st Wed, 19 Nov 2025 08
- Is PRPO a cyclical or defensive stock - Trade Entry Report & Smart Investment Allocation Insights - mfd.ru Sat, 14 Feb 2026 19
- Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow - Zacks Investment Research Wed, 19 Nov 2025 08
- Precipio, Inc. Reports Strong Q3-2025 Financial Results with 30% Revenue Growth and Positive Adjusted EBITDA - Quiver Quantitative Fri, 14 Nov 2025 08
- Trading the Move, Not the Narrative: (PRPO) Edition - Stock Traders Daily Fri, 16 Jan 2026 12
- Precipio: Cash Flow Positivity May Remove Going Concern Language (undefined:PRPO) - Seeking Alpha hu, 07 Aug 2025 07
- Precipio, Inc. Reports Strong Q1-2025 Financial Performance with 43% Revenue Growth - Nasdaq Wed, 14 May 2025 07
- The Truth About Precipio Inc (PRPO): Tiny Stock, Huge Hype – Or Total Trap? - AD HOC NEWS Sun, 04 Jan 2026 08
- How rising interest rates impact PRPO stock - July 2025 Setups & AI Optimized Trade Strategies - mfd.ru hu, 12 Feb 2026 17
- Precipio (PRPO) Eliminates Major Debts and Enhances Financial St - GuruFocus hu, 15 Jan 2026 08
- (PRPO) Volatility Zones as Tactical Triggers - Stock Traders Daily Mon, 05 Jan 2026 08
- Is PRPO a potential multi bagger - Quarterly Performance Summary & AI Forecasted Entry and Exit Points - mfd.ru Sun, 15 Feb 2026 12
- Precipio Adopts Performance-Based Stock Options for 2025 - TipRanks hu, 16 Jan 2025 08
- Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited) - TradingView ue, 25 Feb 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 520 | 12480 | — | Stock Award(Grant) at price 24.00 per share. | LAPORTE KATHLEEN D | Director | — | 2026-01-15 00:00:00 | D |
| 1 | 546 | 13104 | — | Stock Award(Grant) at price 24.00 per share. | COHEN DAVID SETH | Director | — | 2026-01-15 00:00:00 | D |
| 2 | 437 | 10488 | — | Stock Award(Grant) at price 24.00 per share. | COSSMAN JEFFREY M.D. | Director | — | 2026-01-15 00:00:00 | D |
| 3 | 406 | 9744 | — | Stock Award(Grant) at price 24.00 per share. | VALAURI CHRISTINA RIZOPOULOS | Director | — | 2026-01-15 00:00:00 | D |
| 4 | 20 | 468 | — | Purchase at price 23.40 per share. | SABET AHMED ZAKI | Chief Operating Officer | — | 2026-01-02 00:00:00 | D |
| 5 | 20 | 468 | — | Purchase at price 23.40 per share. | SABET AHMED ZAKI | Chief Operating Officer | — | 2026-01-02 00:00:00 | D |
| 6 | 711 | 12499 | — | Stock Award(Grant) at price 17.58 per share. | LAPORTE KATHLEEN D | Director | — | 2025-10-15 00:00:00 | D |
| 7 | 568 | 9985 | — | Stock Award(Grant) at price 17.58 per share. | ANDREWS RONALD ASBURY | Director | — | 2025-10-15 00:00:00 | D |
| 8 | 568 | 9985 | — | Stock Award(Grant) at price 17.58 per share. | ANDREWS RONALD ASBURY | Director | — | 2025-10-15 00:00:00 | D |
| 9 | 746 | 13115 | — | Stock Award(Grant) at price 17.58 per share. | COHEN DAVID SETH | Director | — | 2025-10-15 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -2.70M | -6.04M | -11.28M | -8.17M |
| TotalUnusualItems | 0.00 | 1.72M | 631.00K | 1.12M |
| TotalUnusualItemsExcludingGoodwill | 0.00 | 1.72M | 631.00K | 1.12M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -4.29M | -5.85M | -12.20M | -8.53M |
| ReconciledDepreciation | 1.51M | 1.52M | 1.52M | 1.44M |
| ReconciledCostOfRevenue | 10.97M | 9.18M | 6.90M | 6.46M |
| EBITDA | -2.70M | -4.32M | -10.65M | -7.05M |
| EBIT | -4.22M | -5.83M | -12.17M | -8.50M |
| NetInterestIncome | -74.00K | -18.00K | -12.00K | -20.00K |
| InterestExpense | 74.00K | 18.00K | 12.00K | 20.00K |
| NormalizedIncome | -4.29M | -7.57M | -12.83M | -9.65M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -4.29M | -5.85M | -12.20M | -8.53M |
| TotalExpenses | 22.75M | 22.82M | 22.21M | 18.46M |
| TotalOperatingIncomeAsReported | -4.22M | -7.62M | -12.80M | -9.61M |
| DilutedAverageShares | 1.47M | 1.30M | 1.14M | 1.05M |
| BasicAverageShares | 1.47M | 1.30M | 1.14M | 1.05M |
| DilutedEPS | -2.93 | -4.51 | -10.73 | -8.00 |
| BasicEPS | -2.93 | -4.51 | -10.73 | -8.00 |
| DilutedNIAvailtoComStockholders | -4.29M | -5.85M | -12.20M | -8.53M |
| NetIncomeCommonStockholders | -4.29M | -5.85M | -12.20M | -8.53M |
| NetIncome | -4.29M | -5.85M | -12.20M | -8.53M |
| MinorityInterests | 0.00 | -25.00K | -13.00K | |
| NetIncomeIncludingNoncontrollingInterests | -4.29M | -5.85M | -12.18M | -8.52M |
| NetIncomeContinuousOperations | -4.29M | -5.85M | -12.18M | -8.52M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -4.29M | -5.85M | -12.18M | -8.52M |
| OtherIncomeExpense | 1.78M | 631.00K | 1.12M | |
| OtherNonOperatingIncomeExpenses | 65.00K | 25.00K | ||
| SpecialIncomeCharges | 0.00 | 1.72M | 25.00K | 847.00K |
| OtherSpecialCharges | -1.72M | -25.00K | -847.00K | |
| GainOnSaleOfSecurity | 606.00K | 269.00K | ||
| NetNonOperatingInterestIncomeExpense | -74.00K | -18.00K | -12.00K | -20.00K |
| InterestExpenseNonOperating | 74.00K | 18.00K | 12.00K | 20.00K |
| OperatingIncome | -4.22M | -7.62M | -12.80M | -9.61M |
| OperatingExpense | 11.78M | 13.64M | 15.31M | 12.01M |
| OtherOperatingExpenses | 11.78M | 13.64M | 15.31M | 12.01M |
| GrossProfit | 7.56M | 6.02M | 2.51M | 2.39M |
| CostOfRevenue | 10.97M | 9.18M | 6.90M | 6.46M |
| TotalRevenue | 18.53M | 15.20M | 9.41M | 8.85M |
| OperatingRevenue | 18.58M | 15.41M | 8.42M | 7.78M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| PreferredSharesNumber | 2.59M | 2.59M | 2.59M | 2.59M |
| OrdinarySharesNumber | 1.49M | 1.42M | 1.14M | 1.14M |
| ShareIssued | 1.49M | 1.42M | 1.14M | 1.14M |
| TotalDebt | 1.25M | 1.12M | 1.39M | 1.43M |
| TangibleBookValue | 225.00K | 1.61M | 2.53M | 9.85M |
| InvestedCapital | 12.47M | 14.77M | 16.69M | 24.75M |
| WorkingCapital | -820.00K | 541.00K | 1.35M | 9.27M |
| NetTangibleAssets | 225.00K | 1.61M | 2.53M | 9.85M |
| CapitalLeaseObligations | 879.00K | 775.00K | 1.00M | 1.24M |
| CommonStockEquity | 12.09M | 14.43M | 16.30M | 24.56M |
| TotalCapitalization | 12.17M | 14.54M | 16.44M | 24.72M |
| TotalEquityGrossMinorityInterest | 12.09M | 14.43M | 16.37M | 24.60M |
| MinorityInterest | 0.00 | 0.00 | 65.00K | 40.00K |
| StockholdersEquity | 12.09M | 14.43M | 16.30M | 24.56M |
| RetainedEarnings | -102.44M | -98.15M | -92.30M | -80.09M |
| AdditionalPaidInCapital | 114.52M | 112.56M | 108.59M | 104.43M |
| CapitalStock | 15.00K | 14.00K | 11.00K | 227.00K |
| CommonStock | 15.00K | 14.00K | 11.00K | 227.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 4.90M | 3.67M | 5.14M | 5.83M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 631.00K | 531.00K | 776.00K | 1.62M |
| DerivativeProductLiabilities | 0.00 | 606.00K | ||
| LongTermDebtAndCapitalLeaseObligation | 631.00K | 531.00K | 776.00K | 1.02M |
| LongTermCapitalLeaseObligation | 554.00K | 425.00K | 642.00K | 856.00K |
| LongTermDebt | 77.00K | 106.00K | 134.00K | 160.00K |
| CurrentLiabilities | 4.27M | 3.14M | 4.36M | 4.21M |
| CurrentDeferredLiabilities | 232.00K | 110.00K | 119.00K | 18.00K |
| CurrentDeferredRevenue | 232.00K | 110.00K | 119.00K | 18.00K |
| CurrentDebtAndCapitalLeaseObligation | 622.00K | 585.00K | 616.00K | 414.00K |
| CurrentCapitalLeaseObligation | 325.00K | 350.00K | 361.00K | 388.00K |
| CurrentDebt | 297.00K | 235.00K | 255.00K | 26.00K |
| OtherCurrentBorrowings | 297.00K | 235.00K | 255.00K | 26.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 955.00K | 754.00K | 491.00K | 718.00K |
| PayablesAndAccruedExpenses | 2.46M | 1.69M | 3.13M | 3.06M |
| CurrentAccruedExpenses | 1.67M | 783.00K | 1.00M | 1.05M |
| InterestPayable | 19.00K | 19.00K | 19.00K | 19.00K |
| Payables | 791.00K | 909.00K | 2.13M | 2.01M |
| TotalTaxPayable | 173.00K | 287.00K | 91.00K | 148.00K |
| AccountsPayable | 618.00K | 622.00K | 2.04M | 1.86M |
| TotalAssets | 17.00M | 18.10M | 21.50M | 30.44M |
| TotalNonCurrentAssets | 13.54M | 14.42M | 15.79M | 16.96M |
| OtherNonCurrentAssets | 45.00K | 76.00K | 129.00K | 179.00K |
| GoodwillAndOtherIntangibleAssets | 11.87M | 12.82M | 13.77M | 14.72M |
| OtherIntangibleAssets | 11.87M | 12.82M | 13.77M | 14.72M |
| NetPPE | 1.63M | 1.52M | 1.90M | 2.06M |
| AccumulatedDepreciation | -1.63M | -1.38M | -1.10M | -833.00K |
| GrossPPE | 3.26M | 2.90M | 3.00M | 2.90M |
| ConstructionInProgress | 86.00K | 30.00K | 34.00K | 138.00K |
| OtherProperties | 1.93M | 1.75M | 1.95M | 2.02M |
| MachineryFurnitureEquipment | 1.24M | 1.12M | 1.01M | 737.00K |
| CurrentAssets | 3.45M | 3.68M | 5.71M | 13.48M |
| OtherCurrentAssets | 539.00K | 495.00K | 521.00K | 549.00K |
| Inventory | 724.00K | 384.00K | 708.00K | 564.00K |
| Receivables | 799.00K | 1.30M | 1.04M | 697.00K |
| AccountsReceivable | 799.00K | 1.30M | 1.04M | 697.00K |
| AllowanceForDoubtfulAccountsReceivable | -995.00K | -2.57M | -2.35M | -2.48M |
| GrossAccountsReceivable | 1.79M | 3.87M | 3.39M | 3.18M |
| CashCashEquivalentsAndShortTermInvestments | 1.39M | 1.50M | 3.44M | 11.67M |
| CashAndCashEquivalents | 1.39M | 1.50M | 3.44M | 11.67M |
| CashFinancial | 1.39M | 1.50M | 3.44M | 11.67M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 216.00K | -3.69M | -8.00M | -7.26M |
| RepaymentOfDebt | -657.00K | -503.00K | -365.00K | -209.00K |
| IssuanceOfDebt | 250.00K | 0.00 | 0.00 | |
| IssuanceOfCapitalStock | 78.00K | 2.25M | 129.00K | 16.21M |
| CapitalExpenditure | -223.00K | -126.00K | -277.00K | -682.00K |
| InterestPaidSupplementalData | 85.00K | 42.00K | 45.00K | 34.00K |
| EndCashPosition | 1.39M | 1.50M | 3.44M | 11.67M |
| BeginningCashPosition | 1.50M | 3.44M | 11.67M | 2.66M |
| ChangesInCash | -113.00K | -1.94M | -8.22M | 9.01M |
| FinancingCashFlow | -329.00K | 1.74M | -225.00K | 16.27M |
| CashFlowFromContinuingFinancingActivities | -329.00K | 1.74M | -225.00K | 16.27M |
| NetOtherFinancingCharges | -39.00K | |||
| ProceedsFromStockOptionExercised | 0.00 | 11.00K | 273.00K | |
| NetCommonStockIssuance | 78.00K | 2.25M | 129.00K | 16.21M |
| CommonStockIssuance | 78.00K | 2.25M | 129.00K | 16.21M |
| NetIssuancePaymentsOfDebt | -407.00K | -503.00K | -365.00K | -209.00K |
| NetLongTermDebtIssuance | -407.00K | -503.00K | -365.00K | -209.00K |
| LongTermDebtPayments | -657.00K | -503.00K | -365.00K | -209.00K |
| LongTermDebtIssuance | 250.00K | 0.00 | 0.00 | |
| InvestingCashFlow | -223.00K | -126.00K | -277.00K | -682.00K |
| CashFlowFromContinuingInvestingActivities | -223.00K | -126.00K | -277.00K | -682.00K |
| NetPPEPurchaseAndSale | -223.00K | -126.00K | -277.00K | -682.00K |
| SaleOfPPE | 0.00 | |||
| PurchaseOfPPE | -223.00K | -126.00K | -277.00K | -682.00K |
| OperatingCashFlow | 439.00K | -3.56M | -7.72M | -6.58M |
| CashFlowFromContinuingOperatingActivities | 439.00K | -3.56M | -7.72M | -6.58M |
| ChangeInWorkingCapital | 1.27M | 606.00K | -643.00K | -395.00K |
| ChangeInOtherWorkingCapital | 122.00K | -9.00K | 101.00K | 12.00K |
| ChangeInOtherCurrentLiabilities | -218.00K | -206.00K | -182.00K | -225.00K |
| ChangeInOtherCurrentAssets | 303.00K | 451.00K | 491.00K | -349.00K |
| ChangeInPayablesAndAccruedExpense | 965.00K | 529.00K | -164.00K | 54.00K |
| ChangeInAccruedExpense | 975.00K | 698.00K | -329.00K | -58.00K |
| ChangeInPayable | -10.00K | -169.00K | 165.00K | 112.00K |
| ChangeInAccountPayable | -10.00K | -169.00K | 165.00K | 112.00K |
| ChangeInInventory | -340.00K | 324.00K | -144.00K | -214.00K |
| ChangeInReceivables | 438.00K | -483.00K | -745.00K | 327.00K |
| ChangesInAccountReceivables | 438.00K | -483.00K | -745.00K | 327.00K |
| OtherNonCashItems | 5.00K | -1.72M | -21.00K | 75.00K |
| StockBasedCompensation | 1.88M | 1.74M | 3.80M | 2.03M |
| ProvisionandWriteOffofAssets | 64.00K | 218.00K | 406.00K | -150.00K |
| DepreciationAmortizationDepletion | 1.51M | 1.52M | 1.52M | 1.44M |
| DepreciationAndAmortization | 1.51M | 1.52M | 1.52M | 1.44M |
| Depreciation | 1.51M | 1.52M | 1.52M | 1.44M |
| OperatingGainsLosses | -65.00K | -606.00K | -1.06M | |
| GainLossOnInvestmentSecurities | -606.00K | -269.00K | ||
| GainLossOnSaleOfPPE | 0.00 | |||
| GainLossOnSaleOfBusiness | 0.00 | -65.00K | 0.00 | |
| NetIncomeFromContinuingOperations | -4.29M | -5.85M | -12.18M | -8.52M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for PRPO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|